← Return to Immunotherapy: Keytruda (pembrolizumab)

Discussion

Immunotherapy: Keytruda (pembrolizumab)

Lung Cancer | Last Active: Oct 5, 2023 | Replies (74)
Comment receiving replies
@merpreb

I am not, as of today, a candidate for immune therapy should I need it. I have what is called Multifocal Adenocarcinoma of the lung and for some reason, my type of cancer doesn't respond. I certainly hope that this changes. But I know that many of you take Keytruda. The FDA has approved a higher dose taken less frequently.:https://www.curetoday.com/articles/fda-approves-higher-dose-of-keytruda-across-all-indicated-cancer-types.
Have any of you who are on this medicine been given the new protocol? How are you responding?

Jump to this post

Replies to "I am not, as of today, a candidate for immune therapy should I need it. I..."
Colleen Young, Connect Director | @colleenyoung | Apr 29, 2020

Merry, Thanks for posting this information about the new dosage and protocol of Keytruda (pembrolizumab) for all cancer types for which this drug is used, including lung cancer. I moved your post to this discussion where members are talking about this drug.

I too would like to hear from anyone who is getting the new dose of 400 milligrams (mg) every six weeks instead of the current dose of 200 mg every three weeks.

VIEW AND REPLY